-
Taxonomy & unit
-
us-gaap: USD
-
Description
-
Amount of current income tax expense (benefit) and deferred income tax expense (benefit) pertaining to continuing operations.
-
Summary
-
Bellerophon Therapeutics, Inc. quarterly/annual Income Tax Expense (Benefit) history and growth rate from 2013 to 2022.
- Bellerophon Therapeutics, Inc. Income Tax Expense (Benefit) for the quarter ending March 31, 2023 was -$1.28M.
- Bellerophon Therapeutics, Inc. annual Income Tax Expense (Benefit) for 2022 was -$2.42M, a 34.3% decline from 2021.
- Bellerophon Therapeutics, Inc. annual Income Tax Expense (Benefit) for 2021 was -$1.8M, a 15.3% increase from 2020.
- Bellerophon Therapeutics, Inc. annual Income Tax Expense (Benefit) for 2020 was -$2.13M, a 18% decline from 2019.
Income Tax Expense (Benefit), Trailing 12 Months (USD)
Income Tax Expense (Benefit), Annual (USD)
Income Tax Expense (Benefit), YoY Annual Growth (%)